Two novel mutations in the prothrombin gene cause severe bleeding in a compound heterozygous patient

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 8, 1998, Pages 761-764

  Poort, S R ^a   Njo, K T ^b   Vos, H L ^a   Bertina, R M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Bethesda Hospital   (Netherlands)

Author keywords

Bleeding; Genetic sequence variation; Prothrombin deficiency

Indexed keywords

PROTHROMBIN;

ARTICLE; BLEEDING TENDENCY; CASE REPORT; FAMILY STUDY; FEMALE; GENE MUTATION; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY;

EID: 0032456557     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199811000-00007     Document Type: Article

References (14)

1. Jackson CM. Physiology and biochemistry of prothrombin. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (editors): Haemostasis and thrombosis. Edinburgh: Churchill Livingstone; 1994. pp. 397-438.
2. Royle NJ, Irwin DM, Koschinsky ML, MacGillivray RTA, Hamerton JL. Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively. Somat Cell Mol Genet 1987; 13: 285-292.
3. Degen SJF, Davie EW. Nucleotide sequence of the gene for human prothrombin. Biochemistry 1987; 26: 6165-6177.
4. Tuddenham EGD, Cooper DN. Prothrombin. In: Motuloky AG, Bobrow M, Harper PS, Scriver C (editors): The molecular genetics of haemostasis and its inherited disorders. Oxford: Oxford University Press; 1994. pp. 136-148.
5. Poort SR, Landolfi R, Bertina RM. Compound heterozygosity for two novel missense mutations in the prothrombin gene in a patient with a severe bleeding tendency. Thromb Haemost 1997; 77: 610-615.
6. Krwasczak M, Cooper DN. The human gene mutation database. Trends Genet 1997; 13: 121-122.
7. Bertina RM, Van der Marel-Nieuwkoop W, Loeliger EA. Spectrophotometric assays of prothrombin in plasma of patients using oral anticoagulants. Thromb Haemost 1979; 42: 1296-1305.
8. Poort SR, Michiels JJ, Reitsma PH, Bertina RM. Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 1994; 72: 819-824.
9. Tsiang M, Jain AK, Dunn KE, Rojas ME, Leung LK, Gibbs CS. Functional mapping of the surface residues of human thrombin. J Biol Chem 1995; 270: 16854-16863.
10. Kulozik A, Kugler W, Enssle J, Hentze MW. mRNA metabolism of beta-globin genes carrying premature translational stop mutations. A molecular basis for the recessive and dominant modes of inheritance of beta-thalassemia? Int J Pediatr Hematol Oncol 1997; 4: 499-511.
11. Hoffmeyer S, Nurnberg P, Ritter H, Fahsold R, Leistner W, Kaufmann D, et al. Nearby stop codons in cxons of the neurofibromatosis type 1 gene are disparate splice effectors. Am J Hum Genet 1998; 62: 269-277.
12. Degen SJF. The prothrombin gene and its liver-specific expression. Semin Thromb Haemost 1992; 18: 230-242.
13. Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90: 41-54.
14. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.